Kara, O. Et Al. 2012. Analysis of PTEN, VEGF, HER2 and P53 Status in Determining Colorectal Cancer Benefit from Bevacizumab Therapy. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.13, no.12 , 6397-6401.

Kara, O., Duman, B. B., Kara, B., ERDOĞAN, Ş., PARSAK, C. K., & SAKMAN, G., (2012). Analysis of PTEN, VEGF, HER2 and P53 Status in Determining Colorectal Cancer Benefit from Bevacizumab Therapy. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.13, no.12, 6397-6401.

Kara, Oguz Et Al. "Analysis of PTEN, VEGF, HER2 and P53 Status in Determining Colorectal Cancer Benefit from Bevacizumab Therapy," ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.13, no.12, 6397-6401, 2012

Kara, Oguz Et Al. "Analysis of PTEN, VEGF, HER2 and P53 Status in Determining Colorectal Cancer Benefit from Bevacizumab Therapy." ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.13, no.12, pp.6397-6401, 2012

Kara, O. Et Al. (2012) . "Analysis of PTEN, VEGF, HER2 and P53 Status in Determining Colorectal Cancer Benefit from Bevacizumab Therapy." ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.13, no.12, pp.6397-6401.

@article{article, author={Oguz Kara Et Al. }, title={Analysis of PTEN, VEGF, HER2 and P53 Status in Determining Colorectal Cancer Benefit from Bevacizumab Therapy}, journal={ASIAN PACIFIC JOURNAL OF CANCER PREVENTION}, year=2012, pages={6397-6401} }